Xtant Reports 1Q19 Revenue of $16.7MM, -7% vs. 1Q18

by Mike Evers on May 17, 2019

Xtant reports 1Q19 revenue of USD $16.7MM, -7% vs. 1Q18.

Added 12 new distributors over the last four months
Declining revenues attributable to continued struggles with spinal hardware sales
Focused on cutting costs to generate sufficient cash to fund operations

ORTHOWORLD estimates segment sales and growth...

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

	1Q19	1Q18	$ Chg	% Chg
Spine	$5.7	$6.5	-$0.8	-12.1%
Orthobiologics	$11.0	$11.5	-$0.5	-4.1%
*Total*	*$16.7*	*$17.9*	*-$1.2*	*-7.0%*

Geographic Region	1Q19	1Q18	$ Chg	% Chg
US	$16.0	$17.2	-$1.2	-6.7%
Ex-US	$0.7	$0.8	-$0.1	-12.2%
Total	$16.7	$17.9	-$1.2	-7.0%

1Q19	Amount	% of Sales
Sales	$16.7
Cost of Sales	-$5.9	35.4%
General and Admin	-$4.2	25.1%
Sales and Marketing	-$6.7	40.4%
R & D	-$0.3	1.6%
Other	-$2.4	14.2%
Net Earnings	-$2.8	-16.8%

	1Q19	1Q18	$ Chg	% Chg
Spine	$5.7	$6.5	-$0.8	-12.1%
Orthobiologics	$11.0	$11.5	-$0.5	-4.1%
*Total*	*$16.7*	*$17.9*	*-$1.2*	*-7.0%*

Geographic Region	1Q19	1Q18	$ Chg	% Chg
US	$16.0	$17.2	-$1.2	-6.7%
Ex-US	$0.7	$0.8	-$0.1	-12.2%
Total	$16.7	$17.9	-$1.2	-7.0%

Xtant Reports 1Q19 Revenue of $16.7MM, -7% vs. 1Q18

OUS Sales a Strength for Knee Replacement in 2024

OSSIO Raises $27.6 Million in Funding

Mid-Tier Growth Companies Maintain Torrid Pace in 2024

Paragon 28 Relies on Broad Portfolio to Offset Market Choppiness

Mid-Tier Growth Companies Among Industry’s Best

Get the ORTHOWORLD Newsletter!

Contact Us